MedKoo Biosciences, Inc.
Tel:   +1-919-636-5577    Fax:   +1-919-980-4831    Email:   sales@medkoo.com
Search
Login Register
Search
MedKoo Cat#: 461801 | Name: Sarasinoside A1

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Sarasinoside A1 is a triterpenoid saponin that reverses mesenchymal tumor transformation.

Chemical Structure

Sarasinoside A1
Sarasinoside A1
CAS#114099-54-6

Theoretical Analysis

MedKoo Cat#: 461801

Name: Sarasinoside A1

CAS#: 114099-54-6

Chemical Formula: C62H100N2O26

Exact Mass: 1288.6564

Molecular Weight: 1289.47

Elemental Analysis: C, 57.75; H, 7.82; N, 2.17; O, 32.26

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
Sarasinoside A1; Sarasinoside-A1;
IUPAC/Chemical Name
N-((2S,3S,4R,5R,6R)-2-(((2S,3S,4S,5S)-5-(((2S,3S,4R,5R,6R)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-4-hydroxy-2-(((3S,5R,10R,13S,14R,17S)-4,4,10,13-tetramethyl-17-((R)-6-methyl-4-oxohept-5-en-2-yl)-2,3,4,5,6,7,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl)oxy)tetrahydro-2H-pyran-3-yl)oxy)-6-((((2R,3S,4S,5R,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-(((2S,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)oxy)methyl)-4,5-dihydroxytetrahydro-2H-pyran-3-yl)acetamide
InChi Key
YMIDOMYJFRKBJR-DUJPBWLYSA-N
InChi Code
InChI=1S/C62H100N2O26/c1-25(2)18-29(70)19-26(3)31-11-12-32-30-10-13-39-60(6,7)40(15-17-62(39,9)33(30)14-16-61(31,32)8)88-59-53(47(75)38(24-82-59)87-55-41(63-27(4)68)48(76)43(71)34(20-65)83-55)89-56-42(64-28(5)69)49(77)46(74)37(86-56)23-81-58-54(51(79)45(73)36(22-67)85-58)90-57-52(80)50(78)44(72)35(21-66)84-57/h18,26,31-32,34-59,65-67,71-80H,10-17,19-24H2,1-9H3,(H,63,68)(H,64,69)/t26-,31+,32+,34-,35-,36-,37-,38+,39+,40+,41+,42+,43+,44-,45+,46+,47+,48-,49-,50+,51+,52+,53+,54+,55+,56+,57+,58-,59+,61+,62+/m1/s1
SMILES Code
O=C(/C=C(C)\C)C[C@H]([C@@H]1CC[C@@H]2[C@]1(CCC3=C2CC[C@@H]4[C@]3(CC[C@H](O[C@@H]5OC[C@H](O[C@@H]6O[C@H](CO)[C@H](O)[C@H](O)[C@@H]6NC(C)=O)[C@H](O)[C@@H]5O[C@@H]7O[C@H](CO[C@@H]8O[C@H](CO)[C@H](O)[C@H](O)[C@@H]8O[C@@H]9O[C@H](CO)[C@H]([C@H](O)[C@@H]9O)O)[C@H](O)[C@H](O)[C@@H]7NC(C)=O)C4(C)C)C)C)C
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.03.00
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 1,289.47 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Austin P, Freeman SA, Gray CA, Gold MR, Vogl AW, Andersen RJ, Roberge M, Roskelley CD. The invasion inhibitor sarasinoside A1 reverses mesenchymal tumor transformation in an E-cadherin-independent manner. Mol Cancer Res. 2013 May;11(5):530-40. doi: 10.1158/1541-7786.MCR-12-0385. Epub 2013 Feb 11. PubMed PMID: 23399642. 2: Dai HF, Edrada RA, Ebel R, Nimtz M, Wray V, Proksch P. Norlanostane triterpenoidal saponins from the marine sponge melophlussarassinorum. J Nat Prod. 2005 Aug;68(8):1231-7. PubMed PMID: 16124767. 3: Kitagawa I, Kobayashi M, Okamoto Y, Yoshikawa M, Hamamoto Y. Structures of sarasinosides A1, B1, and C1; new norlanostane-triterpenoid oligoglycosides from the Palauan marine sponge Asteropus sarasinosum. Chem Pharm Bull (Tokyo). 1987 Dec;35(12):5036-9. PubMed PMID: 3451822.